U.S., June 23 -- ClinicalTrials.gov registry received information related to the study (NCT07661888) titled 'Neurofeedback for Episodic Migraine' on June 10.
Brief Summary: Background:
Migraine is a highly prevalent neurological disorder and one of the leading causes of disability worldwide, particularly among women of reproductive age. It is associated with substantial clinical, psychological, and socioeconomic burden, including increased risk of vascular and psychiatric comorbidities, reduced quality of life, sleep disturbances, and decreased productivity. Neurofeedback (NF) has emerged as a promising non-pharmacological intervention aimed at promoting self-regulation of brain activity through real-time feedback and neuroplasticity mech...